Invitae Corp
NYSE:NVTA
Invitae Corp
NYSE:NVTA
Price:
0.019 USD
-35.59%
Market Closed
Updated:
May 4, 2024
EV/OCF
Enterprise Value to OCF
Enterprise Value to OCF
-4.5
Current
-4.5
Median
15.3
Industry
Higher
than median
Lower
than industry value
Enterprise Value to Operating Cash Flow (EV/OCF) ratio is a valuation multiple that measures the value of a company, debt included, to the operating cash flow it generates.
EV/OCF
=-4.5
Enterprise Value
/
1.1B
Operating Cash Flow
-238.2m
All Countries
| Market Cap | EV/OCF | ||||
|---|---|---|---|---|---|
| US |
|
Invitae Corp
NYSE:NVTA
|
5.4m USD | -4.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
94.9B EUR | 10.4 | |
| US |
|
Cigna Corp
NYSE:CI
|
99.9B USD | 10.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
70B USD | 10.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17B USD | 17 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.7B EUR | 6.1 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
15.2B USD | 13.9 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.9B EUR | 8.1 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.5B EUR | 7.9 | |
| US |
|
DaVita Inc
NYSE:DVA
|
11.9B USD | 9.6 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -32.4 |
EV/OCF Forward Multiples
Forward EV/OCF multiple is a version of the EV/OCF ratio that uses forecasted operating cash flow for the EV/OCF calculation. 1-Year, 2-Years, and 3-Years forwards use operating cash flow forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
EV/OCF
N/A
2-Years Forward
EV/OCF
N/A
3-Years Forward
EV/OCF
N/A
You don't have any saved screeners yet
